UA90477C2 - Methods for treating hepatitis c (variants) - Google Patents

Methods for treating hepatitis c (variants)

Info

Publication number
UA90477C2
UA90477C2 UAA200701232A UAA200701232A UA90477C2 UA 90477 C2 UA90477 C2 UA 90477C2 UA A200701232 A UAA200701232 A UA A200701232A UA A200701232 A UAA200701232 A UA A200701232A UA 90477 C2 UA90477 C2 UA 90477C2
Authority
UA
Ukraine
Prior art keywords
methods
variants
treating hepatitis
prevention
treatment
Prior art date
Application number
UAA200701232A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Петер Сеонгву Хванг
Джеймс Такасуги
Хонгью Рен
Ричард Джеральд Вайлд
Антони Турпофф
Александер Арефолов
Гари Митчелл Карп
Гуангминг Чен
Джефри Аллен Кемпбелл
Кристин Эспирите
Консетта Френд
Женгксиан Гу
Такаши Комацу
Original Assignee
ПиТиСи ТЕРАПЬЮТИКС, ИНК.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ПиТиСи ТЕРАПЬЮТИКС, ИНК. filed Critical ПиТиСи ТЕРАПЬЮТИКС, ИНК.
Publication of UA90477C2 publication Critical patent/UA90477C2/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

In accordance with the present invention, compounds that inhibit viral replication, preferably Hepatitis C Virus (HCV) replication, have been identified, and methods for their use provided. In one aspect of the invention, compounds useful in the treatment or prevention of a viral infection are provided. In another aspect of the invention, compounds useful in the treatment or prevention of HCV infection are provided.
UAA200701232A 2004-07-14 2005-07-14 Methods for treating hepatitis c (variants) UA90477C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58748704P 2004-07-14 2004-07-14

Publications (1)

Publication Number Publication Date
UA90477C2 true UA90477C2 (en) 2010-05-11

Family

ID=38744740

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200701232A UA90477C2 (en) 2004-07-14 2005-07-14 Methods for treating hepatitis c (variants)

Country Status (3)

Country Link
CN (1) CN101027051A (en)
UA (1) UA90477C2 (en)
ZA (1) ZA200701235B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9120779B2 (en) * 2008-12-03 2015-09-01 Presidio Pharmaceuticals, Inc. Inhibitors of HCV NS5A
CN102906080A (en) * 2010-03-11 2013-01-30 百时美施贵宝公司 Compounds for the treatment of hepatitis C
CN102816104B (en) * 2012-08-30 2014-05-21 浙江大学 3-cyanoindole compound synthesis method
CN106008488B (en) * 2016-05-20 2018-10-30 广东东阳光药业有限公司 Cyanoindole analog derivative and its preparation method and application
KR20200101402A (en) * 2017-12-19 2020-08-27 브리스톨-마이어스 스큅 컴퍼니 Substituted indole compounds useful as TLR inhibitors

Also Published As

Publication number Publication date
CN101027051A (en) 2007-08-29
ZA200701235B (en) 2009-10-28

Similar Documents

Publication Publication Date Title
EA200700243A1 (en) METHODS OF TREATMENT OF HEPATITIS C
WO2007025043A3 (en) Seven-membered ring nucleosides
WO2007001406A3 (en) Aryl-containing macrocyclic compounds
HK1122292A1 (en) Anti-viral compounds
MY134070A (en) Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
IL192306A0 (en) Anti-viral compounds
WO2001077091A3 (en) Ns5b hcv polymerase inhibitors
NO20063958L (en) HIV integrase inhibitors
BR0309581A (en) Nucleoside derivatives for treatment of hepatitis c virus infection
TW200833662A (en) 4,5-ring annulated indole derivatives and methods of use thereof
WO2004007512A3 (en) Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
WO2004000858A3 (en) Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
WO2004003138A3 (en) Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
MY141003A (en) Materials and methods for treating viral infections with a cysteamine compound
WO2007081517A8 (en) Anti-viral compounds
WO2004014312A3 (en) Small-mer compositions and methods of use
TW200833684A (en) 5,6-ring annulated indole derivatives and methods of use thereof
WO2006033995A3 (en) Thiazolidin-4-ones having anti-hepatitis b activity
WO2004009020A3 (en) Pyrrolopyrimidine thionucleoside analogs as antivirals
WO2006012078A3 (en) Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
NO20064547L (en) Methods for treating HIV infection
MX2009009473A (en) Compounds for the treatment of hepatitis c.
WO2010055164A3 (en) Isoquinolone derivatives as inhibitors of plavivirus replication
WO2010047830A3 (en) Agents for hcv treatment
TW200738700A (en) HIV integrase inhibitors